Cargando…

Minor PNH clones do not distinguish inherited bone marrow failure syndromes from immune-mediated aplastic anemia

Detalles Bibliográficos
Autores principales:	Narita, Atsushi, Miwata, Shunsuke, Imaya, Masayuki, Tsumura, Yusuke, Yamamori, Ayako, Wakamatsu, Manabu, Hamada, Motoharu, Taniguchi, Rieko, Okuno, Yusuke, Muramatsu, Hideki, Takahashi, Yoshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043929/ https://www.ncbi.nlm.nih.gov/pubmed/35073572 http://dx.doi.org/10.1182/bloodadvances.2021006044

Ejemplares similares

Clinical diagnostic value of telomere length measurement in inherited bone marrow failure syndromes
por: Miwata, Shunsuke, et al.
Publicado: (2021)

Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma
por: Imaya, Masayuki, et al.
Publicado: (2022)

Hematological abnormalities in Jacobsen syndrome: cytopenia of varying severities and morphological abnormalities in peripheral blood and bone marrow
por: Yamashita, Daiki, et al.
Publicado: (2023)

Clinical Impact of Melphalan Pharmacokinetics on Transplantation Outcomes in Children Undergoing Hematopoietic Stem Cell Transplantation
por: Maemura, Ryo, et al.
Publicado: (2022)

Clinical and molecular features of CBL-mutated juvenile myelomonocytic leukemia
por: Yoshida, Taro, et al.
Publicado: (2023)

Allogeneic stem cell transplantation with reduced intensity conditioning for patients with adrenoleukodystrophy
por: Kato, Koji, et al.
Publicado: (2018)

Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia
por: Kitazawa, Hironobu, et al.
Publicado: (2021)

LGG-56. INFANTILE HEMISPHERIC BRAIN TUMOR WITH A GOPC-ROS1 FUSION GENE: A CASE REPORT
por: Taniguchi, Rieko, et al.
Publicado: (2020)

Whole-exome analysis of 177 pediatric patients with undiagnosed diseases
por: Narita, Kotaro, et al.
Publicado: (2022)

Characteristics of Taiwanese patients of PNH in the international PNH registry
por: Chou, Wen-Chien, et al.
Publicado: (2016)

Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH)
por: Weisshaar, Kimmo, et al.
Publicado: (2020)

Relationship between immune status after ATG treatment and PNH clone evolution in patients with severe aplastic anemia
por: Wang, Honglei, et al.
Publicado: (2020)

Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort
por: Choi, Chul Won, et al.
Publicado: (2017)

Integration Mapping of piggyBac-Mediated CD19 Chimeric Antigen Receptor T Cells Analyzed by Novel Tagmentation-Assisted PCR
por: Hamada, Motoharu, et al.
Publicado: (2018)

Integrated diagnosis based on transcriptome analysis in suspected pediatric sarcomas
por: Ichikawa, Daisuke, et al.
Publicado: (2021)

A complementary new drug for PNH
por: Brodsky, Robert A.
Publicado: (2020)

Management of paroxysmal nocturnal hemoglobinuria (PNH)
por: Luzzatto, Lucio
Publicado: (2022)

Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry
por: Jang, Jun Ho, et al.
Publicado: (2016)

Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)—report on phases I and II
por: Groth, Martha, et al.
Publicado: (2016)

Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry
por: Schrezenmeier, Hubert, et al.
Publicado: (2020)

Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)—a report on phase III
por: Niedeggen, Cathrin, et al.
Publicado: (2019)

Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria—a pilot study (ePRO-AA-PNH)
por: Bänziger, Silas, et al.
Publicado: (2022)

Clinical parameter-based prediction of DNA methylation classification generates a prediction model of prognosis in patients with juvenile myelomonocytic leukemia
por: Imaizumi, Takahiro, et al.
Publicado: (2022)

Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case–control study in the International PNH Registry
por: Höchsmann, Britta, et al.
Publicado: (2023)

Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
por: Burns, Ethan, et al.
Publicado: (2019)

Pegcetacoplan: A New Opportunity for Complement Inhibition in PNH
por: Weitz, Ilene Ceil
Publicado: (2023)

伴PNH克隆的获得性再生障碍性贫血临床特征及PNH克隆演变分析
Publicado: (2016)

Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH)
por: Lobry, Camille, et al.
Publicado: (2019)

Direct reprogramming of adult adipose-derived regenerative cells toward cardiomyocytes using six transcriptional factors
por: Narita, Shingo, et al.
Publicado: (2022)

Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry
por: Dingli, David, et al.
Publicado: (2023)

PB2040: LACTATE DEHYDROGENASE IS A PREDICTOR OF THROMBOEMBOLISM, AND THROMBOEMBOLISM IS A PREDICTOR OF DEATH, IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): RESULTS FROM A KOREAN PNH REGISTRY
por: Jang, Jun Ho, et al.
Publicado: (2023)

Detection of multiple QTL with epistatic effects under a mixed inheritance model in an outbred population
por: Narita, Akira, et al.
Publicado: (2004)

Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes
por: Sica, Michela, et al.
Publicado: (2017)

No evidence for hypogammaglobulinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with ravulizumab
por: Alashkar, Ferras, et al.
Publicado: (2020)

PB2065: SEVERE HEMOLYSIS OF PNH PATIENTS ASSOCIATED WITH OMICRON INFECTION IN CHINA
por: Yang, Hui, et al.
Publicado: (2023)

P765: MIB2/SUZ12 REGULATED THE PROLIFERATION OF PNH CLONE
por: Zeng, Lijie, et al.
Publicado: (2023)

Quantifying Bone Marrow Fat Fraction and Iron by MRI for Distinguishing Aplastic Anemia from Myelodysplastic Syndromes
por: Zeng, Zhaolong, et al.
Publicado: (2021)

Successful living-donor liver transplantation for sustained liver failure even after resolution of infiltrative massive hepatic invasion of stage 4S neuroblastoma: a case report
por: Jobara, Kanta, et al.
Publicado: (2023)

异基因造血干细胞移植治疗阵发性睡眠性血红蛋白尿症（PNH）与PNH-再生障碍性贫血综合征疗效比较
Publicado: (2019)

P774: SUBSTANTIAL INCREASES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELL CLONE SIZE WITH ORAL IPTACOPAN MONOTHERAPY CONFIRMS CONTROL OF HEMOLYSIS IN COMPLEMENT INHIBITOR-NAÏVE PNH PATIENTS
por: Peffault de Latour, Régis, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0gqp2u4s8geho6cblm9682hurj